Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: A conversation with an institutional investor

I had an interesting chat with a money manager from TD. I asked if he knew about POET. He did not.

I gave my elevator pitch (which, I'm proud to say has become very refined and polished) and he wanted to know more.

On one hand, I was disappointed he hadn't heard about POET. On the other, I'm not really suprised. I asked about exchanges, and whether he's allowed to trade on the Venture. He is, and share price is inconsequential. But he did say that he generally wouldn't trade on the Venture, and that for technology, you're not really a player unless you're on the NASDAQ.

I mentioned the reverse split, and he's seen that uplisting scenario play out often. I was relieved when he didn't immediately freak out about it and give a gloom and doom scenario like many on this board.

Then he talked about opportunity costs, and why a play like POET is not something he would do for his clients. They want percentage increases semi annually. That's really hard to do with a non revenue spec stock on the vulture. He may look like a hero if he made 200-500% gains within a year. But that's rare...and he has to take phone calls when it doesn't happen.

Lastly he talked about traders versus holders, of which I'm a holder. He asked me what my exit point would be. My response was when resolution was imiment. (Either the sale of the company outright, or going to market...in which case I would likely hold longer).

Told me I'm a rare investor, but given the spiel and the belief and understanding I have along with the research I've done, to not trade and stick to my guns.

Share
New Message
Please login to post a reply